RNWAX
Price
$90.29
Change
+$0.57 (+0.64%)
Updated
Sep 16 closing price
Net Assets
74.08B
TEOJX
Price
$10.48
Change
+$0.06 (+0.58%)
Updated
Sep 16 closing price
Net Assets
194.78M
Interact to see
Advertisement

RNWAX vs TEOJX

Header iconRNWAX vs TEOJX Comparison
Open Charts RNWAX vs TEOJXBanner chart's image
American Funds New World R1
Price$90.29
Change+$0.57 (+0.64%)
VolumeN/A
Net Assets74.08B
Transamerica Emerging Markets Eq I2
Price$10.48
Change+$0.06 (+0.58%)
VolumeN/A
Net Assets194.78M
RNWAX vs TEOJX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RNWAX vs. TEOJX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWAX is a Buy and TEOJX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 74.1B vs. TEOJX (195M). TEOJX pays higher dividends than RNWAX: TEOJX (0.12) vs RNWAX (0.00). RNWAX was incepted earlier than TEOJX: RNWAX (23 years) vs TEOJX (6 years). RNWAX (1.66) is less costly to investors than TEOJX (0.90). TEOJX is a more actively managed with annual turnover of: 71.00 vs. RNWAX (37.00). TEOJX has a lower initial minimum investment than RNWAX: TEOJX (0) vs RNWAX (250). TEOJX annual gain was more profitable for investors over the last year : 31.27 vs. RNWAX (16.13). RNWAX return over 5 years is better than : 25.94 vs. TEOJX (13.56).
RNWAXTEOJXRNWAX / TEOJX
Total Expense Ratio1.660.90184%
Annual Report Gross Expense Ratio1.660.90184%
Fund Existence23 years6 years-
Gain YTD22.62731.40072%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets74.1B195M38,000%
Annual Yield % from dividends0.000.12-
Returns for 1 year16.1331.2752%
Returns for 3 years46.7848.9296%
Returns for 5 years25.9413.56191%
Returns for 10 years89.51N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STVN27.231.00
+3.81%
Stevanato Group SpA
DNTH37.470.43
+1.16%
Dianthus Therapeutics
SIMA10.46N/A
N/A
SIM Acquisition Corp I
FERAU10.50N/A
N/A
Fifth Era Acquisition Corp I
CPIX3.36-0.02
-0.59%
Cumberland Pharmaceuticals